{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:44:33Z","timestamp":1792014273221,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T00:00:00Z","timestamp":1527292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stichting Q-support","award":["UMCN140928-00"],"award-info":[{"award-number":["UMCN140928-00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10096-018-3265-z","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T02:06:12Z","timestamp":1527300372000},"page":"1385-1391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Interferon-\u03b3 and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0665-6022","authenticated-orcid":false,"given":"Ruud P. H.","family":"Raijmakers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F. M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan P.","family":"Keijmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teske","family":"Schoffelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Scholzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal P.","family":"Bleeker-Rovers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,26]]},"reference":[{"issue":"9511","key":"3265_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(06)68266-4","volume":"367","author":"NR Parker","year":"2006","unstructured":"Parker NR, Barralet JH, Bell AM (2006) Q fever. Lancet 367(9511):679\u2013688","journal-title":"Lancet"},{"issue":"9006","key":"3265_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(96)91469-5","volume":"347","author":"BP Marmion","year":"1996","unstructured":"Marmion BP et al (1996) Protracted debility and fatigue after acute Q fever. Lancet 347(9006):977\u2013978","journal-title":"Lancet"},{"issue":"9006","key":"3265_CR3","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(96)91470-1","volume":"347","author":"JG Ayres","year":"1996","unstructured":"Ayres JG, Smith EG, Flint N (1996) Protracted fatigue and debility after acute Q fever. Lancet 347(9006):978\u2013979","journal-title":"Lancet"},{"key":"3265_CR4","unstructured":"Shannon, M., The post Q fever debility & fatigue syndrome: an epidemiological study. 1993, University of Adelaide"},{"key":"3265_CR5","doi-asserted-by":"crossref","unstructured":"Kampschreur, L.M., et al., Chronic Q fever in the Netherlands five years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. J Clin Microbiol, 2014","DOI":"10.1128\/JCM.03221-13"},{"key":"3265_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1017\/S0950268812001203","volume":"141","author":"L Kampschreur","year":"2013","unstructured":"Kampschreur L et al (2013) Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect 141:847\u2013851","journal-title":"Epidemiol Infect"},{"issue":"3","key":"3265_CR7","first-page":"20058","volume":"17","author":"W Hoek Van der","year":"2012","unstructured":"Van der Hoek W et al (2012) Relation between Q fever notifications and Coxiella burnetii infections during the 2009 outbreak in the Netherlands. Euro Surveill 17(3):20058","journal-title":"Euro Surveill"},{"issue":"4","key":"3265_CR8","first-page":"478","volume":"72","author":"SP Keijmel","year":"2016","unstructured":"Keijmel SP et al (2016) Altered interferon-gamma response in patients with Q-fever fatigue syndrome. J Inf Secur 72(4):478\u2013485","journal-title":"J Inf Secur"},{"issue":"1","key":"3265_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12879-017-2656-6","volume":"17","author":"AFM Jansen","year":"2017","unstructured":"Jansen AFM et al (2017) CXCL9, a promising biomarker in the diagnosis of chronic Q fever. BMC Infect Dis 17(1):556","journal-title":"BMC Infect Dis"},{"issue":"8","key":"3265_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/cid\/cix013","volume":"64","author":"SP Keijmel","year":"2017","unstructured":"Keijmel SP et al (2017) Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure study): a randomized controlled trial. Clin Infect Dis 64(8):998\u20131005","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3265_CR11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1017\/S0950268815002472","volume":"144","author":"G Morroy","year":"2016","unstructured":"Morroy G et al (2016) The health status of a village population, 7 years after a major Q fever outbreak. Epidemiol Infect 144(6):1153\u20131162","journal-title":"Epidemiol Infect"},{"issue":"11","key":"3265_CR12","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1073\/pnas.0812074106","volume":"106","author":"A Omsland","year":"2009","unstructured":"Omsland A et al (2009) Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci U S A 106(11):4430\u20134434","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3265_CR13","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/cid\/cit129","volume":"56","author":"T Schoffelen","year":"2013","unstructured":"Schoffelen T et al (2013) Specific interferon gamma detection for the diagnosis of previous Q fever. Clin Infect Dis 56(12):1742\u20131751","journal-title":"Clin Infect Dis"},{"key":"3265_CR14","first-page":"247","volume":"64","author":"M Wegdam-Blans","year":"2012","unstructured":"Wegdam-Blans M et al (2012) Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. J Inf Secur 64:247\u2013259","journal-title":"J Inf Secur"},{"issue":"12","key":"3265_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4(12):761\u2013776","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3265_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","volume":"26","author":"K Raemdonck Van","year":"2015","unstructured":"Van Raemdonck K et al (2015) CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev 26(3):311\u2013327","journal-title":"Cytokine Growth Factor Rev"},{"issue":"7","key":"3265_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/1469-0691.12423","volume":"20","author":"T Schoffelen","year":"2014","unstructured":"Schoffelen T et al (2014) A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever. Clin Microbiol Infect 20(7):642\u2013650","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"3265_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1086\/592967","volume":"47","author":"U Vollmer-Conna","year":"2008","unstructured":"Vollmer-Conna U et al (2008) Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis 47(11):1418\u20131425","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3265_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/qjmed\/91.8.549","volume":"91","author":"IA Penttila","year":"1998","unstructured":"Penttila IA et al (1998) Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 91(8):549\u2013560","journal-title":"QJM"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3265-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T19:06:08Z","timestamp":1558811168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,26]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3265-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,26]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All participants provided written informed consent and the study was approved by the Medical Ethical Review Committee of the Arnhem-Nijmegen region.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The samples were analyzed and processed at InnatOss. Anja Scholzen, who helped critically revise the data, is employed by InnatOss as a senior scientist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Medical Ethical Review Committee of the Arnhem-Nijmegen region.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}